ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,375Medicare Part D Prescriptions Filled, Including Refills

Rank: 294 out of 2094

$654K Total Retail Price of All Prescriptions

Rank: 295 out of 2094

184 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 184 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 6,246 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 250 184 1 1
LEVOTHYROXINE SODIUM 231 192 2 3
FUROSEMIDE 197 156 3 6
QUETIAPINE FUMARATE 189 152 4 71
RISPERIDONE 180 146 5 56
DIVALPROEX SODIUM 173 138 6 69
WARFARIN SODIUM 172 164 7 11
AMLODIPINE BESYLATE 157 148 8 2
ENALAPRIL MALEATE 154 139 9 25
DONEPEZIL HCL 153 146 10 20
HYDROCHLOROTHIAZIDE 144 111 11 12
OMEPRAZOLE 144 117 11 4
METFORMIN HCL 137 93 13 8
METOPROLOL TARTRATE 135 98 14 10
ALBUTEROL SULFATE 134 132 15 90
ATORVASTATIN CALCIUM 131 94 16 5
MIRTAZAPINE 119 81 17 43
POTASSIUM CHLORIDE 115 79 18 24
FAMOTIDINE 114 86 19 34
LANTUS 113 68 20 66
OXYCODONE-ACETAMINOPHEN 113 39 S2 20 40
SEROQUEL 109 87 22 172
NAMENDA 103 84 23 32
FENTANYL 91 65 S2 24 68
OLANZAPINE 90 35 25 113
SERTRALINE HCL 88 56 26 26
LISINOPRIL 84 84 27 7
NOVOLOG 84 51 27 116
GABAPENTIN 82 26 29 23
CLONIDINE HCL 79 59 30 62
OXCARBAZEPINE 79 51 30 257
LIDODERM 73 72 32 59
LACTULOSE 71 52 33 65
TAMSULOSIN HCL 71 45 33 29
LEVETIRACETAM 71 53 33 78
TRAZODONE HCL 69 50 36 72
IPRATROPIUM BROMIDE 66 57 37 169
NEXIUM 65 40 38 16
METOPROLOL SUCCINATE 64 54 39 9
CYMBALTA 61 48 40 61
MEGESTROL ACETATE 60 38 R 41 174
CLOPIDOGREL 59 54 42 22
TOPIRAMATE 55 15 43 199
BENZTROPINE MESYLATE 54 28 R 44 157
ZOLPIDEM TARTRATE 53 47 45 14
LIPITOR 53 32 45 39
CARBIDOPA-LEVODOPA 52 51 47 102
BRIMONIDINE TARTRATE 50 37 48 243
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.